The company will deliver an oral presentation on ADRX-0405, its clinical-stage STEAP1 ADC, and a poster presentation on ADRX-0134, its preclinical Na ...
BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...
Company Announcement <li /> AbbVie Inc. files complaint against Genmab in the U.S. District Court for the W ...
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), formerly known as Aadi Bioscience, Inc., an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Linkers Industries Limited received a Nasdaq deficiency letter due to insufficient share bid price, with 180 days to regain compliance. Linkers Industries Limited, a manufacturer of wire and cable ...
Linkers Industries (LNKS) announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On March 10, Linkers Industries received a letter from the Listing Qualifications staff of The Nasdaq ...
New York, March 13, 2025 (GLOBE NEWSWIRE) -- Linkers Industries Limited (Nasdaq: LNKS) (the “Company”), a manufacturer and a supplier of wire/cable harnesses with operation in Malaysia ...
New York, March 13, 2025 (GLOBE NEWSWIRE) -- Linkers Industries Limited (Nasdaq: LNKS) (the "Company”), a manufacturer and a supplier of wire/cable harnesses with operation in Malaysia, today ...
Peptide-drug conjugates (PDCs) represent an emerging class of targeted therapeutic agents that consist of small molecular drugs coupled to multifunctional peptides through cleavable or non-cleavable ...
The industry is also focused on designing linkers that cleave with specificity in order to reduce off-target effects. Recent developments in this space such as the use of enzyme-cleavable linkers, ...